TNNT1Gene1 paper studies itLatestThe Journals of Gerontology, Series A·Jun 16Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin AReviewUrolithin APaper
The Journals of Gerontology, Series A·Jun 16Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin AReviewUrolithin APaper